Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institut für Transfusionsmedizin und Immunologie in Mannheim is a prominent German institution focused on transfusion medicine, immunology, and the development of advanced cellular therapies. As part of the German Red Cross (DRK) Blood Donor Service Baden-Württemberg - Hessen and a partner of the Medical Faculty Mannheim at Heidelberg University, it serves as a critical hub for blood supply and specialized diagnostics. The institute is renowned for its work in hematopoietic stem cell transplantation, HLA typing, and GMP-compliant manufacturing of cell-based medicinal products. Its research activities bridge basic immunology and clinical application, particularly in the fields of oncology and regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut für Transfusionsmedizin und Immunologie.